Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-François Timsit

Showing results (1-10 of 421) with videos related to

Pageof 43
Sort By:
Critical Care (London, England)|January 17, 2013
Topical honey: for bears, not for ICU catheters?Jean-François Timsit
Current Opinion in Critical Care|September 1, 2007
Diagnosis and prevention of catheter-related infectionsJean-François Timsit
Critical Care (London, England)|August 29, 2006
Attributable cost of methicillin resistance: an issue that is difficult to evaluateJean-François Timsit
Critical Care (London, England)|December 17, 2005
Open the intensive care unit doors to HIV-infected patients with sepsisJean-François Timsit
Current Opinion in Critical Care|August 6, 2025
Infection risks in patients treated by continuous renal replacement therapy and extracorporeal membrane oxygenationAntoine Gaillet, Jean-François Timsit
Current Opinion in Infectious Diseases|February 19, 2020
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infectionFrançois Barbier, Jean-François Timsit
Antibiotics (Basel, Switzerland)|January 22, 2024
Impact of Multiplex PCR in the Therapeutic Management of Severe Bacterial PneumoniaJulien Dessajan, Jean-François Timsit
Journal of Clinical Medicine|May 14, 2025
Role of Respiratory Viruses in Severe Acute Respiratory FailureDavid Mokrani, Jean-François Timsit
Current Opinion in Infectious Diseases|December 10, 2019
Carbapenem use in critically ill patientsJuliette Patrier, Jean-François Timsit
Antibiotics (Basel, Switzerland)|March 27, 2026
Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections-A Comprehensive ReviewDespoina Koulenti, Jean-François Timsit
Pageof 43

Showing results (1-10 of 421) with videos related to

Sort By:
Pageof 43
Critical Care (London, England)|January 17, 2013
Topical honey: for bears, not for ICU catheters?Jean-François Timsit
Current Opinion in Critical Care|September 1, 2007
Diagnosis and prevention of catheter-related infectionsJean-François Timsit
Critical Care (London, England)|August 29, 2006
Attributable cost of methicillin resistance: an issue that is difficult to evaluateJean-François Timsit
Critical Care (London, England)|December 17, 2005
Open the intensive care unit doors to HIV-infected patients with sepsisJean-François Timsit
Current Opinion in Critical Care|August 6, 2025
Infection risks in patients treated by continuous renal replacement therapy and extracorporeal membrane oxygenationAntoine Gaillet, Jean-François Timsit
Current Opinion in Infectious Diseases|February 19, 2020
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infectionFrançois Barbier, Jean-François Timsit
Antibiotics (Basel, Switzerland)|January 22, 2024
Impact of Multiplex PCR in the Therapeutic Management of Severe Bacterial PneumoniaJulien Dessajan, Jean-François Timsit
Journal of Clinical Medicine|May 14, 2025
Role of Respiratory Viruses in Severe Acute Respiratory FailureDavid Mokrani, Jean-François Timsit
Current Opinion in Infectious Diseases|December 10, 2019
Carbapenem use in critically ill patientsJuliette Patrier, Jean-François Timsit
Antibiotics (Basel, Switzerland)|March 27, 2026
Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections-A Comprehensive ReviewDespoina Koulenti, Jean-François Timsit
Pageof 43